American Association for Cancer Research Annual Meeting

Healio.com brings you the highlights from the American Association for Cancer Research Annual Meeting. Refer back to this page often to read the latest news from AACR, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting NewsPerspective

Surgery prolongs survival in HER2-positive advanced breast cancer

April 2, 2019
ATLANTA — Primary tumor resection prolonged survival among women with HER2-positive stage IV breast cancer, according to results of a…
Meeting NewsPerspective

Excess body weight earlier in life may have greater influence on pancreatic cancer mortality risk

April 2, 2019
ATLANTA — Excess body weight before age 50 years may increase pancreatic cancer mortality risk to a greater degree than excess weight at older…
Meeting NewsPerspective

Next-generation TRK inhibitor demonstrates efficacy in tumors with emergent resistance mutations

April 2, 2019
ATLANTA — BAY 2731954 appeared safe and demonstrated clinical activity among patients with solid tumors that harbored NTRK gene fusions and had…
Meeting News

'Tremendous progress' in cancer research leads to 'ferocious competition' for funding, outgoing NCI director says

April 1, 2019
ATLANTA — The cancer research engine is “clearly working,” with an influx of new scientists and groundbreaking discoveries…
Meeting NewsPerspective

Autologous cell vaccine prolongs survival in newly diagnosed glioblastoma

April 1, 2019
ATLANTA — An autologous cell vaccine composed of glioblastoma tumor cells and an antisense molecule against insulin-like growth factor type 1…
Meeting News

Moderate-to-vigorous exercise achievable, beneficial for older, obese breast cancer survivors

April 1, 2019
ATLANTA — Older, sedentary, obese breast cancer survivors experienced favorable changes in body composition after a 3-month weight loss…
Meeting NewsPerspective

Umbralisib yields ‘highly encouraging’ results in marginal zone lymphoma

April 1, 2019
ATLANTA — Single-agent umbralisib provided effective PI3K-delta inhibition and appeared well-tolerated among patients with relapsed/refractory…
Meeting News

Apalutamide-based triplet shows promise for metastatic castration-resistant prostate cancer

April 1, 2019
ATLANTA — The combination of apalutamide, abiraterone acetate and docetaxel induced a high rate of PSA decline and measurable disease response…
Meeting NewsPerspective

Immunotherapy, chemotherapy combination shows promising antitumor activity in metastatic pancreatic cancer

April 1, 2019
ATLANTA — The combination of the experimental CD40 antibody APX005M with nivolumab and standard chemotherapy demonstrated a manageable safety…
Meeting NewsPerspective

Oral contraceptive birth control reduces risk for aggressive ovarian cancer

April 1, 2019
ATLANTA — Oral contraceptive use appeared associated with a reduced risk for highly fatal aggressive ovarian cancer, with a greater risk…